Curated Lectures
Immune aging & NAD+
Targeting CD38 against aging
Eric Verdin, MD
President and CEO, Buck Institute for Research on Aging
Eric Verdin presents at ARDD 2025 on CD38, an enzyme that breaks down NAD+, and why it has become a target in research on immune aging and metabolism.
Curated public lecture, shared for education. The speaker is not affiliated with Youthful Vitality & Longevity Medicine and does not endorse its services.
